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      Physiologically-based pharmacokinetic models (PBPK models) have been playing an 
important role in assessing the dynamic relationship between internal dose and 
environmental exposure to hazardous chemicals. However, numerous model parameters 
with often very limited study subjects make statistical analysis difficult to justify. Bois et 
al (1996) and Gelman, Bois, and Jiang (1996) successfully applied the MCMC 
simulation technique in PBPK model parameter estimation problem. However, their 
approach attributed the random variations in internal concentrations to measurement 
error only, which may not be the case in real life. Due to the complexity of body 
metabolic mechanism, stochastic variations (process error) other than the deterministic 
model should be taken into account. In addition, this source of variation may surpass 
measurement error owing to advances in laboratory techniques nowadays. This report 
considers both process error and measurement error simultaneously. First, by adding 
random variations to the deterministic model and simplified to linear case, we obtain 
system of stochastic differential equations. Integrating through Ito integral, the resultant 
equations of internal concentrations become familiar state-space model with 
measurement error. The Kalman filter technique is then employed to obtain the posterior 
distributions of concentrations and parameters given concentrations. The MCMC 
technique is finally applied to generate the required samples after convergence. 
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1. ?? 
The assessment of biological concentrations of a person exposed to hazardous chemicals helps 
industrial hygienists in determining how much risk one may develop certain diseases more 
precisely than environmental exposure monitoring. To find the relationship between 
environmental exposure and the corresponding internal concentrations, physiologically based 
pharmacokinetic (PBPK) models that describe the dynamic internal concentrations within body 
tissues have become popular in recent years (Leung, 1992; Thomas, et al, 1996; Reitz, et al, 
1996). Specifically, PBPK models not only helps industrial hygienists to propose biological 
exposure indexes (BEIs) in more biological media and at different sampling times, it can also be 
used to simulate a wide variety of exposure conditions (Leung, 1992).  
     By dividing the whole body of a person into 4 (or 5) different groups of tissues: fat, muscle 
(slowly perfused), richly perfused, liver, and assuming that all metabolism takes place in the liver, 
dynamic concentrations within each compartment at time t can be determined by solving the 
mass-balance equations for each of the compartments. Specifically, let the fat, muscle, richly 
perfused, and liver compartments be denoted by 4,3,2,1=k , respectively. The concentrations for 
the non-liver compartments satisfy the equation 
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are the concentrations in the arterial blood and venous blood at time t, respectively, )(tCinh  is the 
chemical concentration in inhaled air, )(tCk  is the chemical concentration in the k -th 
compartment at time t, alvQ  is the alveolar ventilation, kQ , kV , and kλ  are the blood flow rate, 
volume, and tissue-blood partition coefficient of the k -th compartment, respectively. Also, bλ  
is blood-air partition coefficient, cQ  is the cardiac output, maxV  is the maximum rate of 
metabolism, mK  is the Michaelis-Menten kinetic constant, and fK  is the first order metabolic 
constant. 
     To fit in the unknown parameters of the PBPK model for internal concentrations in practice, 
researchers of the field often obtain the partition coefficients kλ  and bλ  from literature, kV  
and alvQ  are proportional to individual body weight, and kQ  are proportional to alvQ . And the 
metabolic constants maxV , mK , and fK  are obtained by scaling allometrically the in vivo value 
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determined in laboratory animals with gas uptake techniques (see, e.g., Leung, 1992). Variations 
of the internal concentrations are then obtained by assigning statistical distributions to the 
parameters (Thomas, et al, 1996; Wu, et al, 2002). However, since these unknown model 
parameters are different for each individual, and the best fitting values are only empirical based 
on often very limited measurements, the results may not be legitimate for statistical inferences. 
2. ???? 
In this report, to estimate the PBPK model parameters more adequately, we consider the 
stochastic variations of internal concentrations together with measurement error. The most 
important direct impact would be statistical inferences based on the estimated model parameters, 
especially body burden calculated from accumulated predicted compartment (such as liver or 
fatty tissue) concentrations. Another important application is retrospectively from sample internal 
concentrations to assess environmental exposure concentration, which is difficult to assess in 
most cases. However, the latter case is of direct concern to public population. The latter serves as 
two major goals in our follow-up projects.  
3. ???? 
To estimate the PBPK model parameters with formal statistical approach, Bois et al (1996) and 
Gelman, Bois, and Jiang (1996) employed the Markov Chain Monte Carlo (MCMC) simulation 
technique for population modeling with informative prior distributions for the parameters. Given 
the observations and the prior information, random samples of the parameters are generated from 
their posterior distributions. These values are then fitted into the PBPK model to obtain the 
internal concentrations at time t using the Runge-Kutta numerical integration method. Differences 
of the expectations and the observations are attributed to measurement error. Updated 
observations can be obtained from the posterior distribution of the measurement error, from 
which new set of parameters are again generated. The procedure is repeated until large enough 
samples are generated from their stationary distributions after convergence. 
      Though the approach using MCMC simulations successfully reflects population 
parameters distributions upon convergence. Due to complexity of human body metabolic 
mechanism, the deterministic models represented by the mass-balance equations (1) and (2) are 
subject to stochastic variations, which should also be taken into account. That is, successive 
observations in time may depart from the trajectory predicted by the deterministic model. And 
special attention should be dealt with this source of error other than measurement error as well. 
4. ???? 
In this report, we approximate equation (2) into a linear form, and rewrite equations (1) and (2) as 
stochastic differential equations by adding stochastic variations. The solutions together with 
equations (3) and (4) are then transformed into a dynamic linear state-space model, the 
established Bayesian methodology using the Kalman filter is then employed for the unobserved 
compartment concentrations. Together with the MCMC simulations, samples of the unknown 
population parameters are then generated for statistical inferences. 
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5. ????? 
The methodology of the proposed approach has already been completed. Numerical results such 
as real example analysis and simulations are working in progress. It is expected that the complete 
manuscript for submission for publication is no later than the end of February, 2005. The results 
are expected to be the mainstream in PBPK model statistical research. Not only the results correct 
Bois et al’s main framework, which is oversimplified. But it also successfully brings in 
state-space model structure naturally together with MCMC simulation technique. The developed 
methodology is further applied to backward estimation of (unknown) individual environmental 
exposure based on blood sampling measurements. 
???? 
Bois, F. Y., Jackson, E. T., Pekari, K., and Smith, M. T. (1996) Population 
 toxicokinetics of Benzene. Environmental Health Perspectives, 104, supplement 6, 
1405-1411. 
Carter, C. K., and Kohn, R. (1994) On Gibbs sampling for state space models. 
 Biometrika, 81, 541-553. 
Frühwirth-Schnatter, S. (1994) Data augmentation and dynamic linear models. 
 Journal of Time Series Analysis, 15, 183-202. 
Gamerman, D. (1997) Markov Chain Monte Carlo, Chapman & Hall, London. 
Gelman, A., Bois, F. Y., and Jiang, J. (1996) Physiological pharmacokinetic analysis 
 using population modeling and informative prior distributions. Journal of the 
 American Statistical Association, 91(436), 1400-1412. 
Klebaner, F. C. (1998) Introduction to Stochastic Calculus with Applications, Imperial 
 College Press. 
Leung, H.-W. (1992) Use of physiologically based pharmacokinetic models to 
 establish biological exposure indexes. American Industrial Hygiene Association 
 Journal, 53(6), 369-374. 
Reitz, R. H., Gargas, M. E., Andersen, M. E., Provan, W. M., and Green, T. L. (1996) 
   Predicting cancer risk from vinyl chloride exposure with a physiologically based 
   pharmacokinetic model. Toxicology and Applied Pharmacology, 137, 253-267.  
Rubin, D. B. (1987) A noniterative sampling/important resampling alternative to the 
 data augmentation algorithm for creating a few imputations when fractions of 
 missing information are modest: the SIR algorithm, comment to a paper by Tanner 
 and Wong. Journal of the American Statistical Association, 82, 543-546. 
Thomas, R. S., Bigelow, P. L., Keefe, T. J., and Yang, R. S. H. (1996) Variability in 
 biological exposure indices using physiologically based pharmacokinetic 
 modeling and Monte Carlo simulation. American Industrial Hygiene Association 
 Journal, 57, 23-32. 
West, M., and Harrison, J. (1999) Bayesian Forecasting and Dynamic Models, 2nd ed., 
Springer-Verlag, New York, Inc. 
 5
 
 
